The effect of amantadine on levodopa-induced dyskinesias in Parkinson's disease: A double-blind, placebo-controlled study

被引：125
|
作者：
Snow, BJ [1 ]
Macdonald, L [1 ]
Mcauley, D [1 ]
Wallis, W [1 ]
机构：
[1] Auckland Hosp, Dept Neurol, Auckland, New Zealand
来源：
CLINICAL NEUROPHARMACOLOGY | 2000年 / 23卷 / 02期
关键词：
amantadine; Parkinson's disease; dyskinesia;
D O I：
10.1097/00002826-200003000-00004
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
We performed a double-blind, placebo-controlled, crossover study to assess the effect of amantadine versus placebo on levodopa-induced dyskinesias in Parkinson's disease. We found a 24% reduction in the total dyskinesia score after amantadine administration (p = 0.004). This improvement was achievement without any influence on the severity of "on" period parkinsonism. The results confirm that amantadine reduces levodopa dyskinesias and support the hypothesis that dyskinesias can be reduced by blockade of excitatory pathways in the basal ganglia.
引用
收藏
页码：82 / 85
页数：4
相关论文
共 50 条
  • [1] Antidyskinetic effects of levetiracetam on levodopa-induced dyskinesias in Parkinson's disease: a randomised, double-blind, placebo-controlled trial
    Loehle, M.
    Wolz, M.
    Strecker, K.
    Schneider, C.
    Schwanebeck, U.
    Reichmann, H.
    Graehlert, X.
    Schwarz, J.
    Storch, A.
    [J]. PARKINSONISM & RELATED DISORDERS, 2009, 15 : S116 - S117
  • [2] Amantadine reduces the duration of levodopa-induced dyskinesia:: A randomized, double-blind, placebo-controlled study
    da Silva-Júnior, FP
    Braga-Neto, P
    Monte, FS
    de Bruin, VMS
    [J]. PARKINSONISM & RELATED DISORDERS, 2005, 11 (07) : 449 - 452
  • [3] Levetiracetam for levodopa-induced dyskinesia in Parkinson’s disease: a randomized, double-blind, placebo-controlled trial
    Martin Wolz
    Matthias Löhle
    Karl Strecker
    Uta Schwanebeck
    Christine Schneider
    Heinz Reichmann
    Xina Grählert
    Johannes Schwarz
    Alexander Storch
    [J]. Journal of Neural Transmission, 2010, 117 : 1279 - 1286
  • [4] Levetiracetam for levodopa-induced dyskinesia in Parkinson's disease: a randomized, double-blind, placebo-controlled trial
    Wolz, Martin
    Lohle, Matthias
    Strecker, Karl
    Schwanebeck, Uta
    Schneider, Christine
    Reichmann, Heinz
    Graehlert, Xina
    Schwarz, Johannes
    Storch, Alexander
    [J]. JOURNAL OF NEURAL TRANSMISSION, 2010, 117 (11) : 1279 - 1286
  • [5] Beneficial effect of levetiracetam on levodopa-induced dyskinesias in Parkinson's disease: A double-blind, placebo-controlled, crossover study (the VALID-PD study). Preliminary results
    Stathis, P.
    Konitsiotis, S.
    Tagaris, G.
    Hadjigeorgiou, G.
    Kiriakakis, V.
    [J]. MOVEMENT DISORDERS, 2008, 23 (01) : S202 - S202
  • [6] Botulinum toxin type A (BTX-A) in the management of levodopa-induced cervical dyskinesias in Parkinson's disease: A double-blind, randomized, placebo-controlled crossover study
    Vaughan, J. E.
    Duker, A. P.
    Jones, N.
    Gartner, M.
    Sahay, A.
    Revilla, F. J.
    Espay, A. J.
    [J]. MOVEMENT DISORDERS, 2009, 24 : S285 - S285
  • [7] Clozapine improves dyskinesias in Parkinson disease - A double-blind, placebo-controlled study
    Durif, F
    Debilly, B
    Galitzky, M
    Morand, D
    Viallet, F
    Borg, M
    Thobois, S
    Broussolle, E
    Rascol, O
    [J]. NEUROLOGY, 2004, 62 (03) : 381 - 388
  • [8] Amantadine for the treatment of levodopa-induced dyskinesias in Parkinson's disease.
    Cersosimo, MG
    Scorticati, MC
    Micheli, FE
    [J]. MEDICINA-BUENOS AIRES, 2000, 60 (03) : 321 - 325
  • [9] Amantadine against dyskinesias in Parkinson's disease: a cross-over, double-blind, randomized placebo-controlled trial
    Sawada, H.
    Oeda, T.
    Kuno, S.
    Nomoto, M.
    Yamamoto, K.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2009, 16 : 553 - 553
  • [10] Sarizotan as a treatment for dyskinesias in Parkinson's disease:: A double-blind placebo-controlled trial
    Goetz, Christopher G.
    Damier, Philippe
    Hicking, Christine
    Laska, Eugene
    Mueller, Thomas
    Olanow, C. Warren
    Rascol, Olivier
    Russ, Hermann
    [J]. MOVEMENT DISORDERS, 2007, 22 (02) : 179 - 186
12345